JOHN MOORE: Open Payments
NPI 1669552550 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 23 payments from 11 companies in 2025. Trend: 2023 $409 · 2024 $205 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 3 | $183 |
| Insulet Corporation | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Amgen Inc. | 1 | $135 |
| Lilly USA, LLC | 5 | $95 |
| ABBVIE INC. | 2 | $46 |
| Corcept Therapeutics | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Attruby, OMNIPOD, EVENITY, MOUNJARO, AIRSUPRA, BREZTRI, Korlym, QULIPTA.
Industry payments across AK — which companies pay providers there.
